Modification of Microbial Polymalic Acid With Hydrophobic Amino Acids for Drug-Releasing Nanoparticles

Alberto Lanz-Landázuri1, Montserrat García-Alvarez1, José Portilla-Arias2

  • 1Departament d'Enginyeria Química, Universitat Politècnica de Catalunya, ETSEIB, Diagonal 647, 08028, Barcelona, Spain.

Macromolecular Chemistry and Physics
|June 24, 2014
PubMed

Insights

Biodegradable nanoparticles were synthesized from microbial poly(β, l-malic acid) and amino acid esters. These biocompatible nanoparticles effectively encapsulated and released anticancer drugs, showing potential for drug delivery applications.

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Nanotechnology

Background:

  • Microbial poly(β, l-malic acid) is a biodegradable polymer with potential applications in drug delivery.
  • Developing amphiphilic copolymers is crucial for creating effective nanoparticle drug delivery systems.

Purpose of the Study:

  • To synthesize and characterize amphiphilic copolymers from microbial poly(β, l-malic acid) and amino acid esters.
  • To prepare and evaluate the biocompatibility of nanoparticles derived from these copolymers.
  • To assess the drug loading and release profiles of anticancer drugs encapsulated within these nanoparticles.

Main Methods:

  • Modification of poly(β, l-malic acid) with l-leucine ethyl ester or l-phenylalanine methyl ester.
  • Preparation of nanoparticles using the dialysis-precipitation method.
  • In vitro cell viability assays.
  • Drug encapsulation and release studies with temozolomide and doxorubicin.

Main Results:

  • Amphiphilic copolymers were successfully synthesized and degraded under physiological conditions.
  • Spherical nanoparticles (70-230 nm) were formed with no observed cytotoxicity.
  • Differential release rates were observed for temozolomide (hours) and doxorubicin (weeks).

Conclusions:

  • The synthesized copolymers form safe and effective nanoparticles for drug delivery.
  • The nanoparticles exhibit tunable drug release kinetics, suitable for different therapeutic needs.
  • These biodegradable nanoparticles represent a promising platform for cancer therapy.

Related Concept Videos

Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
172
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
156
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
137